Home/Filings/4/0000897069-24-001526
4//SEC Filing

GONZALEZ RICHARD A 4

Accession 0000897069-24-001526

CIK 0001551152other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 4:40 PM ET

Size

14.9 KB

Accession

0000897069-24-001526

Insider Transaction Report

Form 4
Period: 2024-07-17
GONZALEZ RICHARD A
Chairman of the Board and CEO
Transactions
  • Exercise/Conversion

    Option (Right To Buy)

    2024-07-1787,0500 total
    Exercise: $61.36From: 2018-02-16Exp: 2027-02-15Common Stock (87,050 underlying)
  • Exercise/Conversion

    Option (Right To Buy)

    2024-07-17119,41859,709 total
    Exercise: $79.02From: 2020-02-21Exp: 2029-02-20Common Stock (119,418 underlying)
  • Exercise/Conversion

    Option (Right To Buy)

    2024-07-1776,377152,755 total
    Exercise: $93.50From: 2021-02-20Exp: 2030-02-19Common Stock (76,377 underlying)
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2024-07-17$61.36/sh+87,050$5,341,388600,149 total
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2024-07-17$79.02/sh+119,418$9,436,410719,567 total
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2024-07-17$93.50/sh+76,377$7,141,250795,944 total
  • Sale

    Common Stock, $0.01 par value

    2024-07-17$175.00/sh282,845$49,497,875513,099 total
Footnotes (1)
  • [F1]Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Documents

1 file

Issuer

AbbVie Inc.

CIK 0001551152

Entity typeother

Related Parties

1
  • filerCIK 0001239127

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:40 PM ET
Size
14.9 KB